Q1 2022 Holdings
Filed 2022-05-16 | 64 holdings | $84.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $58.7M | 499,824 | 69.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $13.6M | 176,533 | 16.1% |
| Bicycle Therapeutics PLC(BCYC) | ADR | 088786108 | $7.2M | 163,559 | 8.5% |
| Cytokinetics Inc(CYTK) | COMM | 23282W605 | $2.3M | 62,944 | 2.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COMM | 03237H101 | $1.3M | 100,000 | 1.5% |
| Karuna Therapeutics Inc | COMM | 48576A100 | $247.6K | 1,953,077 | 0.3% |
| Natera Inc(NTRA) | COMM | 632307104 | $126.2K | 3,102,960 | 0.1% |
| Cincor Pharma, Inc. | COMM | 17240Y109 | $97.8K | 5,573,949 | 0.1% |
| Vera Therapeutics, Inc.(VERA) | CL A | 92337R101 | $74.7K | 3,181,442 | 0.1% |
| Aerovate Therapeutics, Inc. | COMM | 008064107 | $68.9K | 3,758,686 | 0.1% |
| Invesco QQQ Trust Series 1(QQQ)Put | COMM | 46090E103 | $63.4K | 175,000 | 0.1% |
| AstraZeneca PLC(AZN) | ADR | 046353108 | $36.7K | 553,903 | 0.0% |
| United Therapeutics Corp(UTHR) | COMM | 91307C102 | $35.7K | 199,183 | 0.0% |
| iShares Russell 2000 ETF(IWM)Put | COMM | 464287655 | $30.8K | 150,000 | 0.0% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $26.1K | 2,194,278 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COMM | 92532F100 | $24.8K | 95,003 | 0.0% |
| Horizon Therapeutics PLC | COMM | G46188101 | $24.5K | 232,894 | 0.0% |
| Dexcom Inc(DXCM) | COMM | 252131107 | $20.6K | 40,265 | 0.0% |
| Regenxbio Inc(RGNX) | COMM | 75901B107 | $20.4K | 614,085 | 0.0% |
| Zoetis Inc(ZTS) | COMM | 98978V103 | $20.1K | 106,574 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | COMM | 75615P103 | $19.7K | 602,545 | 0.0% |
| Sierra Oncology Inc | COMM | 82640U404 | $18.3K | 572,297 | 0.0% |
| Spdr S&P Biotech Etf(XBI)Put | COMM | 78464A870 | $18.0K | 200,000 | 0.0% |
| Iveric Bio Inc(OPHTEUR) | COMM | 46583P102 | $17.2K | 1,021,211 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COMM | 89422G107 | $17.0K | 658,249 | 0.0% |
| Guardant Health Inc(GH) | COMM | 40131M109 | $15.9K | 239,995 | 0.0% |
| ChemoCentryx Inc(CCXIEUR) | COMM | 16383L106 | $14.4K | 573,684 | 0.0% |
| Nextcure, Inc | COMM | 65343E108 | $13.0K | 2,671,856 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COMM | 74366E102 | $13.0K | 547,441 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COMM | 87164F105 | $12.5K | 717,064 | 0.0% |
| Checkmate Pharmaceuticals Inc | COMM | 162818108 | $11.5K | 3,606,707 | 0.0% |
| Inhibrx Inc(INBXUSD) | COMM | 45720L107 | $11.5K | 514,640 | 0.0% |
| Immatics NV(IMTX) | COMM | N44445109 | $10.1K | 1,268,063 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COMM | 481116101 | $10.1K | 1,481,219 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COMM | 12648L601 | $9.1K | 1,952,691 | 0.0% |
| Adicet Bio Inc(TORCEUR) | COMM | 007002108 | $8.3K | 416,289 | 0.0% |
| Inozyme Pharma, Inc. | COMM | 45790W108 | $8.3K | 2,028,308 | 0.0% |
| Bolt Biotherapeutics, Inc.(BOLT1EUR) | COMM | 097702104 | $7.5K | 2,754,437 | 0.0% |
| ChemoCentryx IncCall | CALL | 16383L906 | $7.5K | 300,000 | 0.0% |
| Galera Therapeutics, Inc(GRTX) | COMM | 36338D108 | $7.3K | 3,083,712 | 0.0% |
| Xencor Inc(XNCR) | COMM | 98401F105 | $7.3K | 273,992 | 0.0% |
| Akouos, Inc. | COMM | 00973J101 | $7.2K | 1,515,074 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $7.2K | 4,749,623 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COMM | 803607100 | $6.9K | 88,880 | 0.0% |
| ImmunoGen Inc(IMGNEUR) | COMM | 45253H101 | $6.8K | 1,428,169 | 0.0% |
| Nucana Plc | ADR | 67022C106 | $5.6K | 5,599,999 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COMM | 359616109 | $5.4K | 229,509 | 0.0% |
| Protagonist Therapeutics Inc(PTGX)Call | COMM | 74366E102 | $4.7K | 200,000 | 0.0% |
| Geron Corp(GERN) | COMM | 374163103 | $2.6K | 1,904,762 | 0.0% |
| Pfizer Inc(PFE) | COMM | 717081103 | $2.6K | 49,378 | 0.0% |